June 19, 2025 a 08:38 am
BDX: Analysts Ratings - Becton, Dickinson and Company
Becton, Dickinson and Company (BDX) remains a significant player in the medical supplies and devices industry. Despite experiencing shifts in analyst ratings over recent months, the consensus largely supports the company's robust position in the market. The firm’s broad product portfolio and established market presence continue to attract investor confidence, evidenced by the prevailing analyst 'Hold' ratings, reflecting stability amid market dynamics.
Historical Stock Grades
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 4 | |
| Hold | 11 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment surrounding BDX stock has seen a notable shift over the past few months. Analysts have exhibited a marked movement from 'Strong Buy' towards more conservative stances like 'Hold'. The overall number of ratings has remained steady, suggesting sustained interest but growing caution in recommendations.
- The total number of ratings has remained relatively stable month-over-month.
- A noticeable decrease in 'Strong Buy' ratings from recent months points to a more conservative market outlook.
- 'Hold' ratings have increased, reflecting a neutral stance in the current economic climate.
Percentage Trends
A significant transition in analyst sentiment is evident in the percentage trends across categories. While 'Strong Buy' recommendations have diminished, 'Hold' ratings have become more prevalent, indicating analyst caution. This shift suggests a pivot from aggressive buying to maintained positions, reflecting a balanced outlook for BDX.
- 'Strong Buy' percent decreased from above 20% to under 10% in six months.
- 'Hold' has increased, showcasing a rise from previous months, now constituting over 55% of ratings.
- This distribution indicates analysts adopting a more conservative approach in view of broader market conditions.
- Over the last year, we observe a stabilization in 'Buy' and a decline in highly confident 'Strong Buy' recommendations.
Latest Analyst Recommendations
The recent analyst recommendations highlight a steady stream of 'Maintains' with only a few downgrades. The data suggests a nuanced view of BDX, acknowledging both its strengths and the cautious market perspective.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-03 | Overweight | Overweight | Barclays |
| 2025-05-22 | Neutral | Buy | Citigroup |
| 2025-05-06 | Overweight | Overweight | Morgan Stanley |
| 2025-05-02 | Buy | Buy | Stifel |
| 2025-05-02 | Neutral | Overweight | Piper Sandler |
Analyst Recommendations with Change of Opinion
Several analysts have adjusted their views on BDX, reflecting strategic shifts in assessment. Notably, downgrades to 'Neutral' from 'Buy' illustrate a more reserved approach, yet some previous 'Neutral' ratings have been upgraded, suggesting mixed confidence levels.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-05-22 | Neutral | Buy | Citigroup |
| 2025-05-02 | Neutral | Overweight | Piper Sandler |
| 2025-05-01 | Market Perform | Outperform | William Blair |
| 2024-10-01 | Buy | Neutral | Citigroup |
| 2023-07-24 | Outperform | Market Perform | Raymond James |
Interpretation
The current analyst perspective on Becton, Dickinson and Company implies a cautious yet stable market stance. While sentiments indicate caution with a softening in aggressive 'Buy' signals, the predominance of 'Hold' ratings reflects confidence in the company's enduring market position. The shift in some analysts' views suggests underlying skepticism about immediate growth prospects, yet without significant concern for downturns, fostering a balanced outlook amid an evolving economic landscape.
Conclusion
In conclusion, BDX maintains a solid footing within its sector while analyst sentiment reveals sharpened focus on stability over aggressive growth. With the prevailing ratings split between 'Hold' and 'Buy', opportunities remain tempered by prevailing caution. Analysts signal confidence in BDX's foundational principles but exercise prudence in expectations of rapid valuation increments. For investors, BDX presents a stable yet potentially unmoving stock until market or internal dynamics prompt renewed analyst optimism or strategic adjustments.